Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

  • Segovia-Zafra, Antonio
  • Villanueva-Paz, Marina
  • Serras, Ana Sofia
  • Matilla-Cabello, Gonzalo
  • Bodoque-García, Ana
  • Di Zeo-Sánchez, Daniel E.
  • Niu, Hao
  • Álvarez-Álvarez, Ismael
  • Sanz-Villanueva, Laura
  • Godec, Sergej
  • Milisav, Irina
  • Bagnaninchi, Pierre
  • Andrade, Raúl J.
  • Lucena, M Isabel
  • Fernández-Checa, José C.
  • Cubero, Francisco Javier
  • Miranda, Joana Paiva
  • Nelson, Leonard J.
Idiosyncratic drug-induced liver injury (DILI) is a complex and unpredictable event caused by drugs, and herbal or dietary supplements. Early identification of human hepatotoxicity at preclinical stages remains a major challenge, in which the selection of validated in vitro systems and test drugs has a significant impact. In this systematic review, we analyzed the compounds used in hepatotoxicity assays and established a list of DILI-positive and -negative control drugs for validation of in vitro models of DILI, supported by literature and clinical evidence and endorsed by an expert committee from the COST Action ProEuroDILI Network (CA17112)., This work was supported by grants from the Instituto de Salud Carlos III and Consejería de Salud de Andalucía, cofounded by Fondo Europeo de Desarrollo Regional (FEDER) (PI21/01248, PI19-00883, PT23/00137, PEMP-0127-2020, PI-0310-2018) and Agencia Española del Medicamento y Productos Sanitarios. M.V.P and I.A.A. hold Sara Borrell contracts (CD21/00198 and CD20/00083, respectively). H.N. holds a postdoctoral contract (POSTDOC_21_00780). A.S.Z. holds a Jaume Bosch predoctoral contract funded by CIBERehd (CECO-EHD002). D.D.S. holds an iPFIS predoctoral contract funded by ISCIII (IFI21/0034). G.M.C. holds an FPU PhD fellowship from the Spanish Ministry of Science, Innovation and Universities (FPU22/03868). SCReN and CIBERehd are funded by ISCIII. A.S.S. holds a research scholarship funded by Fundação para a Ciência e a Tecnologia (2021.04902.BD). This publication is based on work from COST Action ‘CA17112 Prospective European Drug-Induced Liver Injury Network’ supported by COST (European Cooperation in Science and Technology); www.cost.eu. We acknowledge the support from grants PID2019-111669RB-100, PID2022-1429560B-I00 and PID2023AEP068 from Plan Nacional de I+D funded by the Agencia Estatal de Investigación (AEI), FEDER and from the CIBEREHD; as well as funding by HORIZON-HLTH-2022-STAYHLTH-02, grant number 101095679; UKRI Horizon Europe Grant 10067052, and support from AGAUR of the Generalitat de Catalunya SGR-2021-00491, and from the Project 201916/31 funded by Fundació Marató TV3. Funding for open access charge: Universidad de Málaga/CBUA., Peer reviewed